| Literature DB >> 18327256 |
Angela Döring1, Christian Gieger, Divya Mehta, Henning Gohlke, Holger Prokisch, Stefan Coassin, Guido Fischer, Kathleen Henke, Norman Klopp, Florian Kronenberg, Bernhard Paulweber, Arne Pfeufer, Dieter Rosskopf, Henry Völzke, Thomas Illig, Thomas Meitinger, H-Erich Wichmann, Christa Meisinger.
Abstract
Serum uric acid concentrations are correlated with gout and clinical entities such as cardiovascular disease and diabetes. In the genome-wide association study KORA (Kooperative Gesundheitsforschung in der Region Augsburg) F3 500K (n = 1,644), the most significant SNPs associated with uric acid concentrations mapped within introns 4 and 6 of SLC2A9, a gene encoding a putative hexose transporter (effects: -0.23 to -0.36 mg/dl per copy of the minor allele). We replicated these findings in three independent samples from Germany (KORA S4 and SHIP (Study of Health in Pomerania)) and Austria (SAPHIR; Salzburg Atherosclerosis Prevention Program in Subjects at High Individual Risk), with P values ranging from 1.2 x 10(-8) to 1.0 x 10(-32). Analysis of whole blood RNA expression profiles from a KORA F3 500K subgroup (n = 117) showed a significant association between the SLC2A9 isoform 2 and urate concentrations. The SLC2A9 genotypes also showed significant association with self-reported gout. The proportion of the variance of serum uric acid concentrations explained by genotypes was about 1.2% in men and 6% in women, and the percentage accounted for by expression levels was 3.5% in men and 15% in women.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18327256 DOI: 10.1038/ng.107
Source DB: PubMed Journal: Nat Genet ISSN: 1061-4036 Impact factor: 38.330